Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Radiopharm Theranostics.
RELATED STOCKHEAD STORIES
Stockhead TV
Tony’s Takeaway: Biotech buffet on the ASX
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who’s been busted playing dress-ups in the US this week?
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Radiopharmaceutical emerges as the hottest space in biotech; here’s what it means for Clarity Pharma
Health & Biotech
ASX Health Stocks: EMV gets strategic US$15m investment from NYSE-listed giant
Health & Biotech
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
Experts
Money Talks: Keep an eye on these tasty precious metal and biotech plays in 2024
Health & Biotech
ASX Health Stocks: Opthea up 13pc on $85m funding from giant investment firm Carlyle, new investor
Health & Biotech
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
Health & Biotech
ASX Health Stocks: Cleo Diagnostics delivers milestones, Radiopharm to begin Phase 1 study
Explainers
ASX cancer stocks guide: Here’s everything you need to know
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
News
